Accepting new patients
Dr.
Prof Michael Dickinson
Haematology
- 🇬🇧
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Prof Michael Dickinson
Professor Michael Dickinson is Lead of the Aggressive Lymphoma stream and provides care for patients with all forms of lymphoma, myeloma, myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). He convenes the Lymphoma Multidisciplinary Meeting (MDM), serves as Deputy Clinical Lead of the CAR-T Centre of Excellence, and is Chair of the Lymphoma Working Party of the Australasian Leukaemia and Lymphoma Group, as well as Chair of the Clinical Research Committee at Peter MacCallum Cancer Centre. Professor Dickinson has a strong focus on drug development and early-phase clinical trials. As Principal Investigator, he has treated the first patient globally in multiple first-in-human studies and has helped take several novel therapies through to registration. He treated the first patients worldwide in trials of glofitamab, a bispecific antibody for lymphoma, as well as epigenetic agents such as BET inhibitors, NKX019 (CAR-NK cells), YTB323 (rapcabtagene autoleucel), and ELARA, a CAR-T registration trial for follicular lymphoma. His team were the first to use YESCARTA and KYMRIAH both in clinical trials and commercially in Australia, and were the highest ex-US recruiters to pivotal CAR-T trials in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. He was the lead investigator in the registration trial of the first-in-class agent glofitamab and has authored more than 100 peer-reviewed publications, including in the New England Journal of Medicine, Nature Medicine, the Journal of Clinical Oncology and Blood. Professor Dickinson is committed to mentoring research fellows and PhD students, supporting their academic and professional development.
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) ·
#-820472
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Haematology
#EB-BFE30D27
Renewal due 2031
Verify with issuerMalpractice cover
AXA Healthcare Liability
1,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2010–2016
MD · Medicine and Surgery
Universidad Complutense de Madrid
-
2016–2020
Residency · Haematology
UAB Barcelona
-
2020–2021
Fellowship · Subspecialty training
Charité Berlin, DE
Career & appointments
-
2020-09–2021-08
Junior consultant
Universidad Complutense de Madrid Teaching Hospital — Haematology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
2,937 |
| Annual physical exam | 99395 |
599 |
| Vaccination administration | 90471 |
999 |
| Minor procedure (skin) | 17110 |
2,824 |
Patient reviews
See all 13"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Haematology — — EuroClinics Patient Choice · 2025 regional
- Excellence in Patient Care — National Society · 2024 national
- Young Investigator Award — European Society · 2023 international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2021
- national college of family doctors — Member · since 2021
- European Union of Medical Specialists (UEMS) — Member · since 2021
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Insurance compatibility
For international patients
Multilingual care
Coordinator: Patient liaison · michael.dickinson@euroclinics.example. Care delivered in English.
Travel & transfer
Aftercare worldwide
Coordinated follow-up by request.
Research & publications
h-index: 5 · i10: 14
Selected publications
-
European registry analysis of Haematology outcomes
DOI: 10.1445/euroclin.2025.0 · cited by 57
-
Outcomes of Haematology in adults — a multi-centre cohort
DOI: 10.1337/euroclin.2024.1 · cited by 19
-
European registry analysis of Haematology outcomes
DOI: 10.2422/euroclin.2023.2 · cited by 13
Show full research record
Additional publications
-
Outcomes of Haematology in adults — a multi-centre cohort
Invited talks
- Practical updates in Haematology · European Annual Congress (Haematology) · Vienna · 2024
- Single-centre experience in Haematology · National Society Meeting · · 2023
Articles by Prof Michael Dickinson
Frequently asked
01. Do you accept new patients?
Prof Michael Dickinson is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
In-network with major international insurers (Allianz Worldwide, AXA Global, BUPA Global and others). Use the "Verify my insurance" button to confirm your plan.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.
Book Prof Michael Dickinson
Similar Haematology specialists
Other verified specialists you may want to compare.